AR and liver cancer: In the analysis of RNA sequencing data, we identified that the master lipogenic transcription factor SREBP1 and the key glycogenic rate-limiting enzyme PYGB were activated and enriched in liver cancer tissues from both ARQ62L and ARE81Q mice, indicating their involvement in the abnormal fat and glycogen metabolism associated with AR mutations in HCC.